{"id":4802,"date":"2020-03-03T14:08:18","date_gmt":"2020-03-03T22:08:18","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=4802"},"modified":"2021-02-23T14:09:17","modified_gmt":"2021-02-23T22:09:17","slug":"antibody-responses-to-sars-cov-2-in-patients-of-novel-coronavirus-disease-2019","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/03\/03\/antibody-responses-to-sars-cov-2-in-patients-of-novel-coronavirus-disease-2019\/","title":{"rendered":"Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019"},"content":{"rendered":"<ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Seroconversion was evaluated for 173 COVID-19 patients in China. Less than 40% of patients showed presence of antibodies during the first 7 days of illness, but this rapidly increased over subsequent days to 100% (Ab), 94.3% (IgM), and 79.8% (IgG). Combining RNA and antibody tests significantly improved diagnostic sensitivity, even in the first 7 days of illness. Higher Ab titer was also associated with increased illness severity.\u00a0<\/span><\/li>\n<\/ul>\n<p><i><span style=\"font-weight: 400\">Zhao et al. (Mar 3, 2020). Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Pre-print downloaded Mar 3 from <\/span><\/i><a href=\"https:\/\/doi.org\/10.1101\/2020.03.02.20030189\"><span style=\"font-weight: 400\">https:\/\/doi.org\/10.1101\/2020.03.02.20030189<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Seroconversion was evaluated for 173 COVID-19 patients in China. Less than 40% of patients showed presence of antibodies during the first 7 days of illness, but this rapidly increased over subsequent days to 100% (Ab), 94.3% (IgM), and 79.8% (IgG). Combining RNA and antibody tests significantly improved diagnostic sensitivity, even in the first 7 days&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/03\/03\/antibody-responses-to-sars-cov-2-in-patients-of-novel-coronavirus-disease-2019\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[],"topic":[19],"class_list":["post-4802","post","type-post","status-publish","format-standard","hentry","category-article-summary","topic-testing-and-treatment"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/4802","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=4802"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/4802\/revisions"}],"predecessor-version":[{"id":4803,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/4802\/revisions\/4803"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=4802"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=4802"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=4802"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=4802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}